CASI Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CASI for the last quarter is 3.41 M USD, and it's 44.03% lower compared to the previous quarter. The net income of Q1 24 is -9.53 M USD.